Charlotte Welinder
21 – 30 of 75
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
The human melanoma proteome atlas-Defining the molecular pathology
(
- Contribution to journal › Article
-
Mark
The Human Melanoma Proteome Atlas-Complementing the melanoma transcriptome
(
- Contribution to journal › Article
- 2020
-
Mark
Novel functional proteins coded by the human genome discovered in metastases of melanoma patients
(
- Contribution to journal › Article
-
Mark
Identification and validation of VEGFR2 kinase as a target of voacangine by a systematic combination of DARTS and MSI
(
- Contribution to journal › Article
- 2019
-
Mark
Clinical protein science in translational medicine targeting malignant melanoma
(
- Contribution to journal › Article
-
Mark
Improved survival prognostication of node-positive malignant melanoma patients utilizing shotgun proteomics guided by histopathological characterization and genomic data
(
- Contribution to journal › Article
-
Mark
Global extracellular vesicle proteomic signature defines U87-MG glioma cell hypoxic status with potential implications for non-invasive diagnostics
(
- Contribution to journal › Article
-
Mark
Anti-tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL-302 in neuroblastoma
(
- Contribution to journal › Article
-
Mark
Ultrasensitive Immunoprofiling of Plasma Extracellular Vesicles Identifies Syndecan-1 as a Potential Tool for Minimally Invasive Diagnosis of Glioma
(
- Contribution to journal › Article
-
Mark
The hidden story of heterogeneous B-raf V600E mutation quantitative protein expression in metastatic melanoma—association with clinical outcome and tumor phenotypes
(
- Contribution to journal › Article